The cannabis testing services market involves the provision of analytical testing services to ensure the safety, potency, and regulatory compliance of cannabis and its derivatives. Polaris Market Research values the market at USD 1884.87 million in 2024, with a CAGR of 17.2% during 2025 to 2034. It is estimated at USD 2204.92 million in 2025 and projected to reach USD 9184.88 million by 2034, with North America the largest market in 2024. Growth is primarily driven by increasing legalization of cannabis for medical and recreational use and by stringent regulatory frameworks that mandate product testing. These services provide accurate, reliable data to producers, regulators, and consumers.

Potency Testing: The Largest Type Segment

Potency testing holds the largest market share by type. The segment's dominance is attributed to the need to quantify cannabinoid content, such as THC and CBD, for regulatory compliance and consumer transparency. Potency data is widely used in product labeling, enabling manufacturers to meet varying legal requirements across regions. It is also essential for medical cannabis products, where precise dosing plays a critical role in therapeutic efficacy.

Terpene Profiling and Comprehensive Testing

As cannabis use becomes more widespread, demand for comprehensive testing that extends beyond potency to include contaminants such as pesticides, heavy metals, residual solvents, and microbial impurities is rising. Terpene profiling has gained traction because terpenes contribute significantly to the therapeutic properties of cannabis. Polaris cites the Journal of Cannabis Research, which indicates that terpene testing requests increased by over 25% between 2020 and 2023, reflecting consumer interest in product differentiation and safety. Residual solvent screening forms part of the same broader scope, and testing laboratories are increasingly offering bundled testing packages to address it. Increased focus on product quality and consumer safety is expected to provide several market opportunities in the coming years.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/cannabis-testing-service-marketEnd Use: Drug Manufacturers Lead

By end use, cannabis drug manufacturers account for the largest market share, owing to the stringent testing requirements imposed on medical and cannabis pharmaceuticals products. These manufacturers rely heavily on testing services to confirm product safety, efficacy, packaging, and regulatory compliance, particularly in highly regulated markets such as North America and Europe. The increasing focus on precision medicine and the development of cannabinoid-based drugs further amplifies demand for robust testing protocols. Eurofins Scientific, a prominent provider with a global presence, offers services such as potency analysis, contaminant screening, and terpene profiling.

Regional Outlook and Industry Developments

North America holds the largest share of revenue, owing to the early legalization of cannabis for medical and recreational use in the US and Canada and a well-established framework that mandates rigorous testing. Europe is a significant market, driven by the legalization of pharmaceutical cannabis in Germany, Italy, and the UK. In September 2024, Eurofins announced the expansion of its cannabis testing capabilities in Europe, adding new facilities in Germany to meet rising demand for medical cannabis quality assurance. Asia Pacific is an emerging market, fueled by the recent legalization of medical cannabis in Thailand, Australia, and New Zealand. On the challenge side, Polaris notes that high costs associated with equipment and operations may present market difficulties. The European Union's standardized regulations encourage cross-border trade, prompting manufacturers to comply with stringent quality standards.

Key Players

•         Eurofins Scientific

•         ALS Global

•         SGS SA

•         Agilent Technologies

•         Shimadzu Corporation

•         Thermo Fisher Scientific

•         Steep Hill

•         CW Analytical Laboratories

•         ProVerde Laboratories

•         Cannalysis

•         EVIO Labs

•         Green Scientific Labs

•         SC Labs

•         MCR Labs

•         Kaycha Labs

Conclusion

Cannabis testing services is becoming an essential layer of quality assurance as legalization expands and rules tighten. With a market value of USD 1884.87 million in 2024 and a projection of USD 9184.88 million by 2034 at a CAGR of 17.2%, laboratories that offer accurate, broad-scope testing are well positioned. For producers, manufacturers, and investors, the priority is to partner with testing providers that can support labeling accuracy, product safety, and the varied requirements of each region.

More Trending Latest Reports By Polaris Market Research:

Gynecological Examination Chairs Market

Fluoropolymers Market

Safari Tourism Market

Enterprise Content Management Market

Automotive Ceramics Market

Mass Flow Controller Market

Hemophilia A Treatment Market

AI Trust, Risk and Security Management Market